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Migraine Associated Vertigo
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The interrelations of migraine and vertigo are complex, eluding a simple localization either centrally or peripherally.  
Spontaneous episodic vertigo, benign paroxysmal positional vertigo, and Meniere’s disease all occur more frequently 
in patients with migraine than in those without. Family studies support a hereditary predisposition to migraine 
associated vertigo. In this review, we discuss definitions, epidemiology, associated syndromes, neurootological 
abnormalities, genetics and treatment for patients with migraine and vertigo.
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INTRODUCTION
The prevalence of all forms dizziness has been 
shown to be higher in people with migraine than in the 
general population with some indicating true damage 
to the inner ear and others implicating problems with 
central vestibular processing. The aim of this review is 
to elucidate some of those associations with specific 
emphasis on migraine associated vertigo.
PROPOSED DEFINITIONS
The 2004 International Headache Society criteria 
for migraine did not recognize migrainous vertigo as 
a headache subtype
1 but several prominent investigators 
have proposed working criteria. Neuhauser et al. have 
required at least two episodes of at least moderately 
severe vertigo concurrent with migrainous features 
which can include headache, photophobia, phonophobia, 
or visual aura.
2  Their definition of vestibular vertigo 
includes: 1] rotational vertigo 2] positional vertigo 3] 
dizziness with nausea and either oscillopsia or imbalance. 
Crevits proposed similar criteria which includes at 
least two attacks of vertigo accompanied by migraine 
headache or visual aura.
3 However, there are no 
uniformly agreed upon definitions of migrainous 
vertigo, or even the terminology. In this review, we will 
refer to episodic vertigo spells that occur concurrently 
with other migraine features as “migrainous vertigo,” 
and episodic vertigo, which occurs in a patient with 
migraine, as “migraine-associated vertigo”. The appli-
cation of the term, “migraine-associated vertigo,” 
does not require that the vertigo and headache occur 
simultaneously.
In order to capture the true relevance of vertigo in 
migraine, we will focus on migraine-associated vertigo.  
Several studies have shown that vertigo attacks and 
migraine headaches often do not occur simultaneously.  
Brantberg and Baloh performed a study of 40 migraine 
patients and 40 relatives with recurrent attacks of Journal of Clinical Neurology: Vol. 3, No. 3, 2007
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rotational vertigo in the absence of hearing loss and 
found that only half of the patients reported ever 
experiencing headache along with vertigo.
4 This was 
consistent with Kayan and Hood’s findings that 36% 
of patients with vertigo and migraine experienced 
vertigo in headache-free periods.
5 In a study by Cutrer 
and Baloh of 91 patients with migraine and vertigo, 
only 5 patients reported a consistent relationship 
between the headaches and vertigo.
6 Oh et al. studied 
24 patients with recurrent vertigo and their family 
members and found a migraine prevalence of 83% in 
probands and 70% (31/44) in relatives who also 
experienced recurrent vertigo. Only 60% (12/20) of 
probands had had some of their migraine headaches 
along with vertigo attacks.
7 When migraine and re-
current vertigo are seen in the same patient, the 
temporal concurrence of these symptoms is somewhere 
between 30-70%.
8-9
EPIDEMIOLOGY
Epidemiological studies have shown a steady pre-
valence of migraine in the United States when care 
is taken to follow strict International Headache 
Society criteria. The rates range from 16-18% for 
women and 5-6% for men.
10,11 The prevalence of 
migraine was shown to be significantly higher at 38% 
in a prospective study of 200 patients recruited from 
a dizziness clinic, with migrainous vertigo specifically 
seen at a prevalence of 7%.
2 Interestingly, in this 
study, the rate of migraine in the control population 
of orthopedic patients was 24%, somewhat higher 
than population averages. In a German population 
survey,
8  1212 of 4077 (30%) participants consenting 
to a telephone interview reported having experienced 
moderate or severe dizziness/vertigo in their lifetimes. 
Of the 1003 participants who eventually completed 
all the required interviews, 243 (24%) reported speci-
fically experiencing vestibular vertigo. Of these 243, 
40% experienced spontaneous rotational vertigo, 43% 
positional vertigo and 17% episodic nausea with 
oscillopsia or imbalance.
8 A follow-up analysis of this 
same data sample showed that 3.2% of participants 
had a history of migraine-associated vertigo and 0.9% 
met their criteria for migrainous vertigo.
12 Twenty 
seven percent of the 200 migraine patients in Kayan 
and Hood’s study experienced vertigo.
5 If applied to 
a population prevalence of migraine of 18% in 
women and 6% in men, this would mean that about 
4.5% of women and 1.5% of men would be expected 
to experience migraine-associated vertigo, which are 
not too dissimilar to the German study’s finding.
MIGRAINE ASSOCIATED VERTIGO 
SYNDROMES
1. Benign recurrent vertigo of childhood
Basser first reported on a syndrome of paroxysmal 
vertigo affecting children generally before the age of 
8.
13 Attacks were brief lasting seconds to minutes and 
had a benign prognosis other than being associated 
with a caloric paresis. Fenichel later showed the 
connection between the disorder and migraine head-
aches.
14 Subsequent long-term follow up studies have 
confirmed the association with migraine, showing 
both a high rate of personal and family history of 
migraine in children with benign paroxysmal vertigo.
15-18 
Additionally, most of these children also suffered from 
motion sickness.
16-18
2. Meniere’s disease
The literature on the association of migraine and 
Meniere’s disease is necessarily confusing as much 
has been printed before the acceptance of clear criteria 
for either disorder and even recent papers do not 
indicate whether the diagnosis of Meniere’s disease 
is based on definite, probable or possible features. It 
is no surprise, therefore, that the prevalence of migraine 
in Meniere’s disease has ranged considerably (22- 
76%),
19-22 though most studies do indicate a higher 
than population baseline of migraine in Meniere’s 
patients. The association is complex, however, because 
migraine can mimic the symptoms of Meniere’s 
disease and migraine may even damage the inner ear Cha YH and Baloh RW. Migraine Associated Vertigo
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causing a delayed endolymphatic hydrops.
23
We observed that certain clinical features are more 
prevalent in patients with migraine and Meniere’s 
disease versus those with Meniere’s disease alone. In 
our study, patients with migraine and Meniere’s 
disease had an earlier age of onset, a higher rate of 
concurrent bilateral hearing loss and greater family 
history of migraine headaches and episodic vertigo 
than patients without migraine.
24 Familial forms of 
Meniere’s disease have been presented throughout 
the years and most of these families also show high 
rates of migraine and episodic vertigo without 
hearing loss
25-28 indicating that a “migraine-Meniere’s” 
syndrome is likely genetically distinct from Meniere’s 
disease alone.
3. Basilar migraine
Though the current IHS criteria do not recognize 
recurrent vertigo as a migraine equivalent symptom, 
vertigo is included as one of the many symptoms of 
basilar migraine. The strict definition of basilar migraine 
requires an aura of bilateral visual field abnormalities 
along with at least two symptoms localizable to the 
brainstem in association with a migraine headache.
1  
Vertigo is one of the most common symptoms in 
basilar migraine.
29 However, the majority of patients 
with migraine and vertigo do not qualify for a diag-
nosis of basilar migraine as the vertigo attacks are 
often separate from the headaches and the duration 
of the vertigo often does not fall within the restrictions 
for aura (5-60 min).
2,4,9,30
4. BPPV
The pathophysiology of benign paroxysmal posi-
tional vertigo (BPPV) relates to degenerating otoconia 
loosened in the labyrinth. Otolith movement causing 
endolymphatic fluid flow creates a brief spell of 
dizziness, which patients usually describe as true 
rotatory vertigo, nausea, light-headedness or imbalance.  
BPPV is associated with brief torsional geotropic- 
beating nystagmus in the head-hanging position
31 and 
is successfully treated with the particle repositioning 
maneuver.
32 This should be distinguished from posi-
tional worsening of symptoms in other forms of vertigo, 
including migrainous vertigo.
33 Several studies have 
shown high prevalence rates of migraine in idiopathic 
BPPV. A retrospective study by Uneri in 476 patients 
with posterior canal variant BPPV revealed a history 
of migraine meeting IHS criteria in 54.8% of patients; 
67.4% of these 476 patients reported a history of 
motion sensitivity, both rates that are much higher 
than population baseline.
34  Ishiyama et al. studied 
247 patients with BPPV and found that a history of 
migraine was 3 times more common in patients with 
idiopathic BPPV than in those who developed it after 
head trauma or surgery.
35 von Brevern et al. performed 
a population based study of patients with dizziness/ 
vertigo using historical criteria for BPPV (at least 5 
attacks of dizziness triggered by typical head position 
changes lasting less than 1 minute). The odds ratio 
for migraine in their BPPV group versus control was 
7.5.
36 These studies indicate that migraine is a risk 
factor for BPPV. Though the mechanism is unknown, 
it may relate to small degrees of ischemic damage to 
the otoliths, perhaps through vasospasm.
23,37
NEUROTOLOGICAL FEATURES
1. Electronystagmographic (ENG) abnormalities
Several studies have observed ENG abnormalities 
in migraine patients though most studies have shown 
that the range of degree of caloric paresis is generally 
mild. Cutrer and Baloh reviewed vestibular testing 
abnormalities in 91 patients with migraine associated 
dizziness and found unilateral vestibular paresis in 
20.9% of the patients.
6 Smaller studies have reported 
similar rates.
38-40 The role of symptomatic vertigo is 
unclear, however, because caloric abnormalities have 
also been observed in migraine patients without a 
history of vestibular symptoms.
39 Given the vagaries 
of caloric testing, one must be cautious in ascribing 
mild degrees of paresis to any particular disorder. 
Subtle abnormalities such as spontaneous nystagmus, 
directional preponderance, and static positional nystagmus Journal of Clinical Neurology: Vol. 3, No. 3, 2007
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have also been observed in migraine patients.
6 Though 
these are generally non-localizing findings, they may 
indicate an imbalance in the vestibular pathways.
Ocular-motor features during acute migrainous 
vertigo attacks were evaluated by von Brevern et al. 
in 20 patients with migraine. Ten patients had features 
of central nystagmus, 3 peripheral nystagmus and 7 
which were indeterminant. All variations of upbeat, 
downbeat, horizontal and torsional nystagmus were 
observed.
41 Kayan and Hood studied electronystag-
mographic recordings in 80 migraine patients in 
between headaches and found central abnormalities 
in 11, peripheral in 6 and indeterminant findings in 
14.
5 These studies highlight the difficulty in ascribing 
a pure central or peripheral localization to migraine 
associated vertigo.
GENETICS
Episodic vertigo occurs in association with rare 
genetic syndromes, some of which have known 
genes.  Several of the episodic ataxias (EA 1,2,3,4) 
have at least some reported features of vertigo
42-45 
but only episodic ataxia type 2 (EA2) has a strong 
association with migraine. About 50% of EA2 patients 
experience migraine headaches, which is no surprise 
as it is allelic with familial hemiplegic migraine 
(FHM) type 1.
43 There is also growing evidence that 
episodic vertigo in association with migraine also has 
a strong genetic component. In Oh’s report on familial 
benign recurrent vertigo of 24 probands, the prevalence 
of spontaneous attacks of vertigo in relatives was 
40% as opposed to 2% in unrelated spouses and was 
also correlated with a high prevalence of migraine 
(46%) in family members.  In 22 of the cases, there 
was more than one generation affected making an 
autosomal dominant pattern of inheritance the most 
likely.
7 The only genetic association study to date 
was on 20 families with episodic vertigo in which at 
least 3 family members were affected. This study 
found an association with 22q12.
46 The majority of 
these patients and family members also had migraine 
headaches.
TREATMENT
When patients with migraine associated vertigo 
present with clear features o f  B P P V  o r  M e n i e r e ’ s  
disease, they should be treated with standard 
treatment for those disorders (particle repositioning 
maneuver for BPPV, diuretics, salt restriction and 
possible surgical intervention for Meniere’s disease). 
Meniere’s attacks associated with prominent headache 
can also be treated with calcium channel blockers.
The management of acute spells depends largely 
on the duration and severity. Severe spells that last 
longer than 20 minutes can be treated pharmaco-
logically. If the patient is able to swallow a pill, then 
oral meclizine, promethazine or prochloperazine can 
be used. We prefer promethazine for its efficacy and 
because it can be substituted 1:1 in the suppository 
form, which can be used if nausea from the vertigo 
is severe. All antiemetics are potentially sedating so 
patients should be adequately warned not to drive 
after taking these medications. Many patients find 
that a good nap or good night’s sleep will break a 
vertigo attack and welcome the sedating effects. 
Benzodiazepines are also effective vestibular suppress-
ants but have the potential for tolerance and dependency 
and should be used with caution.
As is the true for all episodic disorders, the mainstay 
of preventative treatment is to avoid triggers. Many 
patients report triggers for vertigo that are very 
similar to triggers for typical migraine headaches. 
These include stress, lack of sleep, dietary fluctua-
tions, fluctuations in caffeine intake, certain kinds of 
foods, weather changes and menstrual cycles. Controlled 
trials of medications for idiopathic recurrent vertigo are 
lacking but anecdotal reports of the efficacy of aceta-
zolamide have lead to the more widespread use of 
this medication. We find it helpful for patients who 
have clear attacks of rotatory vertigo. The rationale 
for trying acetazolamide, a carbonic anhydrase inhibitor 
was based on the efficacy of this drug in reducing 
recurrent vertigo in patients with EA2.
47 The action 
of acetazolamide in the brain that renders its efficacy 
is still unknown, but P
31MRS have shown that treatment Cha YH and Baloh RW. Migraine Associated Vertigo
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lowers the pH of the extracellular space in patients 
with episodic ataxia.
48 An acidic extracellular environ-
ment leads to decreased neuronal excitability, whereas 
an alkaline environment is associated with increased 
excitability. The main side effects of acetazolamide 
include paresthesias, dehydration, lethargy and some-
times myalgias. Acetazolamide can also decrease 
potassium levels. In general, we start this medication 
at a low dose (125 mg a day) and only increase it 
by 125 mg a week to a goal dose of 250 mg twice 
daily. We encourage patients to drink generous 
amounts of citrus juices to avoid the alkalinization of 
urine, which leads to the formation of kidney stones.
We also use verapamil in the extended release 
form, which works well for patients with recurrent 
vertigo and migraine headaches. A small case series 
of patients with recurrent vertigo and chronic head-
aches showed efficacy with typical anti-migraine 
medications including pizotifen, a calcium channel 
blocker, verapamil and propranolol.
49 The longer 
acting form is associated with fewer drops in blood 
pressure and we are able to use this medication 
frequently in young women who generally have low 
blood pressure.
Selective serotonin reuptake inhibiting medications 
can be effective and are generally most useful in 
patients who have concurrent mood disorders. Chronic 
dizziness of any kind, particularly with unpredictable 
spells, are extremely anxiety provoking and can lead 
to a complex interaction of otogenic and psychogenic 
factors that can lead to prolonged disability.
50 The 
use of SSRIs can help address the vertigo attacks as 
well as the adjustment reaction to the attacks.
CONCLUSION
Numerous studies support migraine as a clear risk 
factor for the development of both central and peri-
pheral forms of vertigo. Like primary migraine head-
ache, migraine-associated vertigo shows a strong genetic 
basis. Recognizing the various forms of migraine- 
associated vertigo is key to the efficient diagnosis, 
treatment, and education of this group of patients, 
from whom much can be learned about the complex 
interrelations of the brain and inner ear.
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